+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Breast Cancer Core Needle Biopsy Market Size, Share and Growth Outlook, 2026: Analysis By Image-Guidance Technology (Ultrasound-Based Breast Biopsy, Mammography-Based , MRI-Based Breast Biopsy, CT-Based Breast Biopsy), By Product Type (Automated , Vacuum-Assisted Core Biopsy Devices, Biopsy Needles and Consumables), By End-User (Hospitals and Surgical Suites, Diagnostic Laboratories and Imaging Centers, Pharmaceutical and Biotechnology Companies, Academic and Cancer Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Breast Cancer Core Needle Biopsy Market size is forecast to increase from $850.98 Million in 2026 to $1234.48 Million in 2034 at a CAGR of 4.76% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006087
Pages: 214 Pages

Breast Cancer Brachytherapy Market Size, Share and Growth Outlook, 2026: Analysis By Technology (High Dose Rate , Low Dose Rate ), By Product Type (Applicators and Afterloaders, Electronic Brachytherapy Systems), By Application (Early-Stage Breast Cancer, Recurring Breast Cancer, Partial Mastectomy & Lumpectomy Procedures), By End-User (Hospitals and Tertiary Care Centers, Oncology and Radiation Therapy Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Cancer Brachytherapy Market size is forecast to increase from $1.48 Billion in 2026 to $2.63 Billion in 2034 at a CAGR of 7.44% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006086
Pages: 220 Pages

Breast Biopsy Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Biopsy Consumables , Biopsy Systems , Specimen Handling Systems), By Guidance Technology (Ultrasound-Guided, Stereotactic-Guided, MRI-Guided), By Application (Screening, Diagnostics, Therapy Response Monitoring), By End-User (Hospitals, Specialized Breast Care Centers, Diagnostic and Imaging Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Biopsy Devices Market size is forecast to increase from $2.56 Billion in 2026 to $4.3 Billion in 2034 at a CAGR of 6.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006085
Pages: 226 Pages

Breast Augmentation Market Size, Share and Growth Outlook, 2026: Analysis By Implant Type (Silicone Implants, Saline Implants, Gummy Bear Implants), By Implant Shape (Round Implants, Anatomical Implants), By Implant Surface (Textured Surface Implants, Smooth Surface Implants), By Procedure Type (Augmentation Mammoplasty, Reconstructive Surgery), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Breast Augmentation Market size is forecast to increase from $2.14 Billion in 2026 to $5.73 Billion in 2034 at a CAGR of 13.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006084
Pages: 210 Pages

Breast Adenocarcinoma Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Chemotherapy, Targeted Therapy, Hormonal Therapy, Immunotherapy, Radiation Therapy), By Route of Administration (Oral, Intravenous, Subcutaneous), By End-User (Hospitals and Cancer Treatment Centers, Specialty Clinics, Ambulatory Surgical Centers, Homecare) Companies, and Country Forecast, 2021 to 2034

Global Breast Adenocarcinoma Treatment Market size is forecast to increase from $31.08 Billion in 2026 to $64.71 Billion in 2034 at a CAGR of 9.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006083
Pages: 218 Pages

Breakthrough Therapy Designation Market Size, Share and Growth Outlook, 2026: Analysis By Therapeutic Modality (Targeted Therapy, Immunotherapy , Gene Therapy, Cell Therapy , Monoclonal Antibodies, Small Molecule Drugs), By Primary Application (Oncology , Rare, Central Nervous System , Infectious Diseases, Cardiovascular & Metabolic Diseases, Pulmonary & Respiratory Diseases), By Treatment Intent (Curative Intent, Disease Modification, Symptom Management), By Development Stage (Pre-Market, Post-Approval Breakthrough Brands) Companies, and Country Forecast, 2021 to 2034

Global Breakthrough Therapy Designation Market size is forecast to increase from $151.08 Billion in 2026 to $449.45 Billion in 2034 at a CAGR of 14.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006082
Pages: 212 Pages

Branded Generics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Alkylating Agents & Antimetabolites, Hormones & Steroids, Anti-Hypertensive Drugs, Lipid Lowering Drugs , Anti-Depressants & Anti-Psychotics, Anti-Epileptics, Antibiotics & Antivirals), By Therapeutic Area (Oncology, Cardiovascular Diseases, Diabetes & Metabolic Disorders, Neurology, Gastrointestinal Diseases, Dermatology, Analgesics & Anti-inflammatory), By Route of Administration (Oral , Parenteral , Topical , Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Government) Companies, and Country Forecast, 2021 to 2034

Global Branded Generics Market size is forecast to increase from $314.31 Billion in 2026 to $532.02 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006081
Pages: 226 Pages

Branched Stent Grafts Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Aortic Branched Stent Grafts, Iliac Branched Stent Grafts, Patient-Specific , Off-the-Shelf Branched Grafts), By Application (Fenestrated Endovascular Aortic Repair , Branched Endovascular Aortic Repair , Thoracic Endovascular Aortic Repair , Chimney), By Indication (Thoracoabdominal Aortic Aneurysms , Pararenal & Juxtarenal Aortic Aneurysms, Iliac Artery Aneurysms, Aortic Dissections), By End-User (Hospitals, Specialty Cardiac & Vascular Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Branched Stent Grafts Market size is forecast to increase from $447.5 Million in 2026 to $816.1 Million in 2034 at a CAGR of 7.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006080
Pages: 221 Pages

Brain Tumor Diagnosis and Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Diagnostic Modalities, Therapeutic Modalities), By Diagnostic Test (Magnetic Resonance Imaging , Computed Tomography , Positron Emission Tomography , Tissue Sampling and Histopathology , Molecular and Genetic Testing, Lumbar Puncture and Cerebral Arteriograms), By Treatment (Surgical Intervention , Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy), By Tumor Classification (Primary Brain Tumors , Secondary ), By End-User (Specialized Oncology Treatment Centers, Multi-Specialty Hospitals and Medical Centers, Ambulatory Surgical Centers , Diagnostic Laboratories and Pathology Testing Units) Companies, and Country Forecast, 2021 to 2034

Global Brain Tumor Diagnosis and Therapeutics Market size is forecast to increase from $3.97 Billion in 2026 to $6.98 Billion in 2034 at a CAGR of 7.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006079
Pages: 222 Pages

Brain PET-MRI Systems Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Traditional , Helium-Free , Fully-Integrated Digital PET-MRI Systems), By System Phase (Pre-Clinical Systems, Clinical Systems), By Clinical Application (Oncology , Neurology , Psychiatry , Cardiology and Functional Vascular Studies), By End-User (Hospitals and Dedicated Nuclear Medicine Suites, Advanced Diagnostic Imaging Centers, Academic, Biomedical, and Cancer Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Brain PET-MRI Systems Market size is forecast to increase from $441.29 Million in 2026 to $718.35 Million in 2034 at a CAGR of 6.28% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006078
Pages: 224 Pages